Skip to main content

Clavicle Fracture

0
Pipeline Programs
4
Companies
4
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Arthrex
ArthrexCA - Santa Barbara
1 program
Arthrex Clavicle PlatesN/A1 trial
Active Trials
NCT04986553Withdrawn0Est. Jul 2023
Zimmer Biomet
Zimmer BiometFL - Jacksonville
1 program
Clavicle open reduction and internal fixationN/A1 trial
Active Trials
NCT05327959Active Not Recruiting98Est. Mar 2027
Stryker
StrykerCA - San Jose
1 program
Clavicle platingN/A1 trial
Active Trials
NCT05579873Unknown336Est. Oct 2025
Frontera Therapeutics
Frontera TherapeuticsChina - Suzhou
1 program
concentric-eccentric strength trainingN/A1 trial
Active Trials
NCT05810129Recruiting39Est. Oct 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Frontera Therapeuticsconcentric-eccentric strength training
StrykerClavicle plating
Zimmer BiometClavicle open reduction and internal fixation
ArthrexArthrex Clavicle Plates

Clinical Trials (4)

Total enrollment: 473 patients across 4 trials

NCT05810129Frontera Therapeuticsconcentric-eccentric strength training

Crossed Education in Relation to Muscle Mass in Patients Operated of Clavicular Fracture

Start: May 2023Est. completion: Oct 202539 patients
N/ARecruiting
NCT05579873StrykerClavicle plating

Double Plating Versus Single Plating Techniques in Midshaft Clavicle Fractures

Start: Nov 2022Est. completion: Oct 2025336 patients
N/AUnknown
NCT05327959Zimmer BiometClavicle open reduction and internal fixation

A.L.P.S. Clavicle Plating System PMCF

Start: May 2022Est. completion: Mar 202798 patients
N/AActive Not Recruiting
NCT04986553ArthrexArthrex Clavicle Plates

A Multi-Center, Prospective Registry to Evaluate the Continued Safety and Performance of Clavicle Plates

Start: May 2021Est. completion: Jul 20230
N/AWithdrawn

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 473 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.